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Abstract
Background: Mastitis is a common problem for breastfeeding women. Researchers have called
for an investigation into the possible role of maternal nasal carriage of S. aureus in the causation of
mastitis in breastfeeding women.
Methods: The aim of the study was to investigate the role of maternal S. aureus nasal carriage in
mastitis. Other factors such as infant nasal S. aureus carriage, nipple damage, maternal fatigue and
oversupply of milk were also investigated. A case-control design was used. Women with mastitis
(cases, n = 100) were recruited from two maternity hospitals in Melbourne, Australia (emergency
departments, breastfeeding clinics and postnatal wards). Breastfeeding women without mastitis
(controls, n = 99) were recruited from maternal and child health (community) centres and the
rooms of a private obstetrician. Women completed a questionnaire and nasal specimens were
collected from mother and baby and placed in charcoal transport medium. Women also collected
a small sample of milk in a sterile jar.
Results: There was no difference between nasal carriage of S. aureus in breastfeeding women with
mastitis (42/98, 43%) and control women (45/98, 46%). However, significantly more infants of
mothers with mastitis were nasal carriers of S. aureus (72/88, 82%) than controls (52/93, 56%). The
association was strong (adjusted OR 3.23, 95%CI 1.30, 8.27) after adjustment for the following
confounding factors: income, private health insurance, difficulty with breastfeeding, nipple damage
and tight bra. There was also a strong association between nipple damage and mastitis (adjusted
OR 9.34, 95%CI 2.99, 29.20).
Conclusion: We found no association between maternal nasal carriage of S. aureus and mastitis,
but nasal carriage in the infant was associated with breast infections. As in other studies of mastitis,
we found a strong association between nipple damage and mastitis. Prevention of nipple damage is
likely to reduce the incidence of infectious mastitis. Mothers need good advice about optimal
attachment of the baby to the breast and access to skilled help in the early postpartum days and
weeks.
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Background
Mastitis is a common problem for breastfeeding women
[1-3] yet it is a poorly researched topic [4]. Mastitis may be
a noninfective inflammation, resolving with heat and
increased breast drainage [5,6], or an infective process
which may lead to a breast abscess [7].
The most commonly isolated organism in lactating
women with mastitis is Staphylococcus aureus (S. aureus):
present in 32% to 44% of breast milk samples [8-11]. S.
aureus is a commensal which may colonise the nostrils,
axillae, vagina and pharynx of 30 to 50% of adults; as well
as damaged skin, such as traumatised nipples of lactating
women [12,13]. When S. aureus are present in the nostrils,
they may act as a reservoir of S. aureus for clinical infec-
tions in the host or may facilitate spread to other people
[14]. A review has concluded that four studies conducted
in the 1990s found that S. aureus nasal carriers had a rela-
tive risk of 7.1 (95%CI 4.6, 11.0) of surgical-site infec-
tions, due to wound colonisation by the patient's
endogenous flora [15].
Researchers have called for an investigation into the pos-
sible role of maternal nasal carriage of S. aureus in the cau-
sation of mastitis [16]. In clinical practice, there is
anecdotal evidence that maternal or infant nasal carriage
may be linked to recurrent mastitis in lactating women
[17]. Our literature review did not identify any studies
investigating the role of maternal or infant nasal carriage
of S. aureus in mastitis. Medline searches (via PubMed)
were conducted using keywords "staph* AND (lactation
OR breastfeeding OR postpartum OR mastitis)" limited to
human studies. A recent update (31 May 2006) has iden-
tified one case study of a mother of premature quadru-
plets who had symptoms of mastitis; methicillin-resistant
S. aureus (MRSA) was isolated in expressed breast milk
and nasal cultures from mother and infants [18].
We conducted a case-control study to examine the possi-
ble role of maternal nasal carriage of S. aureus in the devel-
opment of mastitis. The role of S. aureus nasal carriage in
the infant and other factors reputed to predispose women
to mastitis, such as nipple damage, maternal fatigue and
oversupply of milk, were also assessed.
Method
Cases were women with mastitis attending the Emergency
Department or the Breastfeeding Clinic at the Royal
Women's Hospital or Mercy Hospital for Women in Mel-
bourne, Australia. Mastitis was defined as at least two
breast signs or symptoms (pain, redness or lump) and one
systemic symptom (fever or 'flu-like symptoms) present
for at least twelve hours.
Women in the control group were lactating women (with
babies aged six weeks or less) attending Maternal and
Child Health (MCH) centres in metropolitan Melbourne
(community clinics attended by new mothers). Also,
women attending a private obstetrician for their six-week
postnatal visit were invited to join the study.
After women gave written consent, they completed a ques-
tionnaire about nipple damage, oversupply of milk and
other factors identified as possible predisposing factors
for mastitis. Maternal fatigue was assessed using the four
Vitality questions from the SF-36 [19]. (The SF-36 Health
Survey is one of the most widely used health-related qual-
ity of life questionnaires, measuring eight health concepts,
including Physical functioning, Social functioning and
Vitality) [19]. At the end of the questionnaire for women
with mastitis, participants were asked to describe "how
you have been feeling and how mastitis has affected you";
the results of these open-text comments have been pub-
lished separately [20].
Nasal specimens were collected from mother and baby.
Saline-moistened swabs were rotated around the inside of
the nasal vestibule, then placed in Amies charcoal trans-
port medium. Women used a sterile water wipe to cleanse
her nipple then expressed a small sample of milk in a ster-
ile jar. Specimens were labelled and delivered to the
microbiology laboratory at the Royal Children's Hospital,
where the swabs were inoculated on Mannitol Salt Agar
plates, a medium selective for staphylococci. An aliquot of
expressed breast milk was also placed on a Mannitol Salt
Agar plate. S. aureus was confirmed with DNase test (ther-
mostable nuclease) and antibiotic susceptibility was con-
ducted using standard microbiological methods.
Using Epi-Info 6.0 for an unmatched case-control study
with 95% confidence and 80% power, if 20% of controls
were nasal carriers and 40% of cases, we would need 91
women in each group. We planned to recruit 100 cases
(women with mastitis) and 100 controls (women in the
community). The data were analysed by Stata 8.0 compu-
ter program. The comparability of cases and control
groups were described. Odds Ratios were calculated to
compare exposures in each group, and Mantel-Haenszel
Weighted Odds Ratios where appropriate. Logistic regres-
sion was used to determine factors predictive of mastitis.
Four infants over 6 weeks age were inadvertently recruited
for the control group (two at 7 weeks, one 9 and one 11
weeks). A sensitivity analysis was conducted by repeating
the analysis without these infants and the results were
found to be almost identical: therefore the records of
these four mothers and babies were retained in the sam-
ple.BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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Ethics approval:
• La Trobe University Human Ethics Committee (21/8/02
Project 02-61)
￿ Research and Ethics Committees, Royal Women's Hos-
pital (23/7/02, Project 02/22)
￿ Research Ethics Committee, Mercy Hospital for Women
(17/7/02, Project R02/32)
￿ Department of Human Services, Victoria (5/6/02,
Project 36/02).
Results
One hundred women with mastitis (cases) and ninety-
nine breastfeeding women (controls) were recruited
between August 2002 and April 2004. Recruiting was
stopped as the database incorrectly indicated that 100
controls had been recruited.
Fifty-four women with mastitis were recruited at the
Mercy Hospital for Women and 46 women at the Royal
Women's Hospital; from the breastfeeding clinics (n =
38), readmitted with mastitis in the wards (n = 32) and
through the emergency departments (n = 25; 5 missing
data). Most of the women for the control group were
recruited through MCH centres (n = 70), whilst 29
women were from the private obstetrician.
Characteristics of study population
The background characteristics are displayed in Table 1.
Women with mastitis were older than women in the con-
trol group (34 years and 32 years, p < 0.05), while the
median age of the babies was 16 days for cases and 36
days for controls. Family income was lower in the women
with mastitis and they were less likely to have private
health insurance.
Table 2 shows the health of women and their infants.
After a question to determine if women had experienced
mastitis in the past, women were asked "Have you ever
had any other staph bacterial infections? For example:
boils, abscesses, sores inside your nose?" Women with
mastitis were more likely to have self-reported a past his-
tory of staphylococcal infection(s), 23% compared to
12%.
The sum of the scores from the four Vitality questions in
the SF36 ranged from 4 (low) to 17 (high), with a mean
of 10.7 (n = 195). Women were dichotomised into two
groups scoring above or below the mean, and the groups
compared. Sixty-one percent of women with mastitis
scored below the mean vitality score, compared to 26% of
controls. However, it is possible that some women were
reporting lethargy associated with the onset of mastitis.
The breastfeeding characteristics of the sample can be seen
in Table 3. Cases were more likely to have had nipple pain
(71%) compared to controls (35%), and more likely to be
Table 1: Background characteristics of participants in a case control study of mastitis.
Cases (N = 100) 
n (%)
Controls (N = 99) 
n (%)
Odds Ratio 95% CI Significance*
Mother's age (mean, years) 33.5 31.7 **p = 0.004
Mother's education:
Completed secondary 89 (89) 90 (91) 1.24 0.49 3.13 p = 0.655
Completed tertiary degree 63 (63) 70 (71) 1.02 0.90 1.16 p = 0.779
Family income (n = 184)
up to $50,000 20/92 (22) 10/92 (11)
$50,001–70,000 29/92 (32) 17/92 (19) 0.85 0.32 2.24
more than $70,000 43/92 (47) 65/92 (71) 0.33 0.14 0.77 **p = 0.004
Mother paid work/study 7 (7) 6 (6) 1.20 0.50 2.86 p = 0.687
Private health insurance 51 (51) 78 (80) 0.27 0.14 0.50 **p = 0.000
Baby's age in days
(mean and range) 33.7 (6–728) 34 (13–77) t-test ns
median 16 36
Multiple birth (twins) 3 (3) 3 (3) 0.99 0.19 5.03 p = 0.990
Primiparity 69 (69) 60 (61) 0.69 0.39 1.24 p = 0.216
Caesarean section 35 (35) 32 (32) 1.13 0.63 2.03 p = 0.690
(n = 100 women with mastitis and 99 breastfeeding controls). Melbourne, Australia, 2002–2004.
*chi-square test for all analyses, except t-test for mother's and baby's age.
**statistically significant.
ns = not significant.BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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using purified lanolin on their nipples (64%) than con-
trols (35%). Thirteen cases used topical antifungal cream/
ointment/gel, while nine controls used topical antifungal
treatment (not significant). More cases used nipple
shields (16%) than controls (2%). Cases were also more
likely to have experienced breast engorgement in the pre-
vious week (51%) than controls (19%), were more likely
to say that they had missed a feed (54%) than the controls
Table 3: Breastfeeding characteristics of participants in a case control study of mastitis.
Cases (N = 100)
n (%)
Controls (N = 99)
n (%)
Odds Ratio 95% CI Significance*
Nipple pain 70/99 (71) 35/99 (35) 4.41 2.43 8.02 *p = 0.000
Grazed nipple 47/99 (48) 9/99 (9) 9.04 4.10 19.93 *p = 0.000
Cracked nipple 44/99 (44) 5/99 (5) 15.04 5.63 40.19 *p = 0.000
White spot 16/98 (16) 7/99 (7) 2.56 1.01 6.54 *p = 0.049
Breast engorgement (needed to express) 51/100 (51) 19/99 (19) 1.76 1.19 2.61 *p = 0.005
Blocked duct 52/100 (52) 13/99 (13) 3.70 2.39 5.71 *p = 0.000
Missed feeds 53/99 (54) 36/99 (36) 1.76 1.05 2.93 *p = 0.032
More than 6 hours between feeds 45/100 (45) 38/99 (38) 1.31 0.75 2.31 p = 0.344
Hurrying feeds 38/100 (38) 48/99 (48) 0.92 0.55 1.54 p = 0.745
Feeding less than usual 11/98 (11) 4/99 (4) 0.95 0.70 1.31 p = 0.770
Pressure on breast: bra 37/99 (37) 20/99 (20) 2.36 1.25 4.46 *p = 0.008
Thickness of milk 8/98 (8) 1/99 (1) 0.95 0.62 1.47 p = 0.833
Too much milk 29/100 (29) 17/99 (17) 1.37 1.09 1.73 *p = 0.007
Baby prefers one breast 48/100 (48) 37/99 (37) 1.55 0.88 2.72 p = 0.1293
Amount of breastfeeding:
Fully 77/100 (77) 84/99 (85)
Breast and formula 13/100 (13) 15/99 (15)
Expressing only 10/100 (10) 0/99 (0) *p = 0.005
Lanolin on nipples 64/100 (64) 35/99 (35) 3.25 1.82 5.81 *p = 0.000
Nipple shields 16/100 (16) 2/99 (2) 9.24 2.06 41.35 *p = 0.004
Breast pads 76/100 (76) 85/99 (86) 0.52 0.25 1.08 p = 0.080
Expressing 86/100 (86) 51/99 (51) 5.78 2.90 11.51 *p = 0.000
Always washed nipples 1/100 (1) 1/99 (1) 0.99 0.06 16.05 p = 0.994
Always washed hands 48/100 (48) 41/99 (41) 1.31 0.75 2.29 p = 0.351
(n = 100 women with mastitis and 99 breastfeeding controls). Melbourne, Australia, 2002–2004.
*chi-square test for all analyses.
**statistically significant.
Table 2: Health characteristics of participants in a case control study of mastitis.
Cases (N = 100) 
n (%)
Controls (N = 99) 
n (%)
Odds Ratio 95% CI Significance*
Mother's Health
Breast surgery: 7/100 (7) 5/99 (5) 1.42 0.43 4.62 p = 0.565
Past history staphylococcal infection 23/100 (23) 12/99 (12) 2.17 1.01 4.64 **p = 0.047
Past history candida infection 16/97 (17) 8/95 (9) 2.15 0.87 5.29 p = 0.096
Past history mastitis (previous child) 12/100 (12) 12/99 (12) 0.99 0.42 2.32 p = 0.979
Smoker 5/100 (5) 4/99 (4) 1.25 0.33 4.80 p = 0.745
Anaemic 10/100 (10) 5/99 (5) 2.09 0.69 6.35 p = 0.194
Scored below average on vitality score 
(from SF36)
61/100 (61) 26/99 (26) 4.39 2.41 8.01 **p = 0.000
Baby's Health
Unwell 16/100 (16) 11/98 (11) 1.51 0.66 3.43 p = 0.330
Difficulty breastfeeding 57/100 (57) 14/99 (14) 8.05 4.04 16.05 **p = 0.000
(n = 100 women with mastitis and 99 breastfeeding controls). Melbourne, Australia, 2002–2004.
*chi-square test for all analyses.
**statistically significant.BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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(36%) and that they had too much milk: 29% compared
to 17%. Women were asked about pressure on their
breasts in the previous week. More cases reported pressure
from a tight bra (37%) than controls (20%).
Women with mastitis were more likely to report that their
infant was having difficulty with breastfeeding, 57%, than
the control group, 14%. Ten women with mastitis were
currently feeding their infant expressed breast milk only,
while none of the women in the control group was
expressing only.
Microbiological results
There was no difference between nasal carriage of S. aureus
in women with mastitis (43%) and women in the control
group (46%) (Table 4). The overall proportion of women
with a positive nasal culture for S. aureus was 44.4%
(Binomial Exact 95% CI 37.3, 51.6). (MRSA was not iso-
lated in any specimens in this study).
As expected, the expressed breast milk of women with
mastitis was more likely to be positive for S. aureus (45/
99, 46%), than the milk of controls (15/83, 18%). Most
of the S. aureus isolated from the milk of the controls was
reported as 'sparse" (11/15, 73%). Only one specimen in
the control group was reported as "profuse" (1/15, 7%)
compared to 14/45 (31%) in the mastitis group.
Significantly more infants of mothers with mastitis were
nasal carriers of S. aureus (72/88, 82%) than infants in the
control group (52/93, 56%, OR 3.55, 95%CI 1.80, 7.00).
A high proportion of S. aureus in both groups was
reported as "profuse", 66% of cases and 50% of controls,
59% in total. Overall, 68.5% of infants were nasal carriers
of S. aureus (Binomial Exact 95% CI 61.2, 75.2).
The youngest infants were most likely to be nasal carriers
(91% of infants in the first two weeks in the mastitis
group), compared to 78% of infants aged 5–6 weeks. A
stratified analysis of S. aureus nasal carriage in the infants
was conducted to examine the results in babies at different
ages. The Mantel-Haenszel weighted Odds Ratio was 3.49
(95%CI 1.38, 8.83) for infants of mothers with mastitis to
be nasal carriers compared to infants in the control group
(Table 5).
A statistically significant association was found between
women with a cracked nipple and nasal carriage of S.
aureus  in their infants. Eighty-four percent (38/45) of
women with a cracked nipple had a baby with nasal S.
aureus, compared to 63% (85/135) of women without a
cracked nipple, OR 3.19 (95%CI 1.33, 7.69). However,
there was no association between nasal carriage in the
mother and a cracked nipple: carriage in women with a
cracked nipple was 39% (19/49) compared to 46% (67/
146) of women without a cracked nipple.
Multivariate analysis
A logistic regression model was developed to look at fac-
tors predictive of mastitis. The independent variables of
interest were tested individually against the dependent
variable and were entered in the model if the p-value of
the Wald statistic was ≤ 0.25 [[21], p95]. Where there were
small numbers of missing values, records were deleted
(seven records). Fifteen women had missing values for
income, and sixteen babies did not have a result for nasal
swab. These records were retained with the missing values
coded accordingly. This left 192 records for analysis.
The initial model included the following variables:
mother's age, income (2 levels), private health insurance,
past history of staphylococcal infection, baby having dif-
ficulty with breastfeeding, nipple cracked, engorged
breast/s, missed feed/s, tight bra, too much milk, using
lanolin on nipple/s, baby positive for nasal S. aureus,
mother anaemic, baby prefers one breast. Variables were
eliminated one at a time using logistic regression. Only
those with a p-value of the Wald statistic ≤ 0.05 were
retained in the model. The process was repeated until only
significant variables remained. Then all independent var-
iables eliminated in the original univariate analysis were
added back into the model one at a time to check that
none was now significant given the reduced model. The
lroc test identified that the area under ROC curve was
0.8778, that is a high sensitivity, and the lstat test showed
80.73% correctly classified. The final model (Model 1) is
presented in Table 6.
The adjusted Odds Ratio for infants of mothers with mas-
titis to be nasal carriers was 3.23 (95%CI 1.30, 8.27) after
adjusting for possible confounding factors (Model 1). In
order to explore the effects of breastfeeding factors and
baby nasal carriage without including demographic fac-
tors, a second model was developed (Model 2). Without
including the demographic variables (income and private
health insurance), the second model is very similar to
Model 1. In a third model (not shown), the demographic
variables were included while limiting the analysis to pri-
vate patients (n = 126), and the results were also similar.
A fourth model (not shown, n = 184), excluding all babies
over 7 weeks also found that infant nasal carriage was sig-
nificant (adjusted OR 4.08, 95%CI 1.44, 11.67).
Discussion
Summary of main findings and comparison with existing 
literature
The study showed that there was no difference in the pro-
portion of women with mastitis and without mastitis who
were nasal carriers (43% and 46% respectively). The over-BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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all proportion of women with a positive nasal culture for
S. aureus was 44.4% (95% CI 37.3, 51.6). This is consist-
ent with the mean of 37.2% in general populations calcu-
lated by Kluytmans and colleagues from eighteen studies
in 13,873 people [15], but seems higher than other stud-
ies published in 2004: 29% [22], 24% [23] and 33% [24].
We found that a very high proportion of infants of moth-
ers with mastitis were nasal carriers: 82% and this was sta-
tistically significantly higher than infants of other women
(56%). Infant nasal carriage remained significant after
adjusting for other variables. Younger infants were most
likely to be nasal carriers than older infants in this study.
In a similar manner, Peacock and colleagues found that
40–50% of infants were colonised with S. aureus in the
first eight weeks, falling to 21% by six months [25].
An association was not found between parity or a history
of mastitis and being a case in this study, in contrast to
previous studies [2,16]. This may be related to the high
proportion of primiparous women in both groups of our
study. Also, women with a history of mastitis may have
been more likely to volunteer to be a control than other
women.
The presence of a cracked nipple was associated with a
high odds for mastitis, 9.34 (95%CI 2.99, 29.20), after
adjusting for other factors. Foxman and colleagues also
found an association with "nipple cracks or sores" with an
OR of 3.4 (95%CI 2.04, 5.51) on logistic regression [16].
Prevention of nipple damage is likely to reduce the inci-
dence of infectious mastitis. New mothers need good
advice about optimal attachment of the baby to the breast
Table 5: Babies' nasal results of a case control study of mastitis.
Cases N (%) Controls N (%)
S. aureus pos S. aureus neg S. aureus pos S. aureus neg Odds Ratio 95% CI
Babies 1–2 w 41 (91) 42   (67) 1 6.67 0.08 156.3
Babies 3–4 w 22 (82) 51 7   (53) 15 3.71 0.99 15.45
Babies 5–6 w 7 (78) 23 3   (59) 23 2.52 0.42 26.64
Babies >6 w 2 (29) 50   (0) 2
Total 72 (82) 16 52 (56) 41 3.49* 1.38 8.83
(n = 88 infants of mothers with mastitis and 93 control infants), Melbourne, Australia, 2002–2004: stratified by age.
*Mantel-Haenszel Weighted Odds Ratio.
w = week(s).
Table 4: S. aureus results of a case control study of mastitis.
Cases (N = 100)
n (%)
Controls (N = 99)
n (%)
Odds Ratio 95% CI Significance*
Mother
Nasal swab positive for S. aureus 42/98 (43) 45/98 (46) 0.88 0.50 1.55 p = 0.666
Sparse 23 15
Moderate 10 21
Profuse 8 8 p = 0.0614
Expressed breast milk positive for S. aureus 45/99 (46) 15/86 (17) 3.94 1.99 7.81 **p = 0.000
Sparse 17 11
Moderate 14 3
Profuse 14 1 **p = 0.0339
Baby
Nasal swab positive for S. aureus 72/88 (82) 52/93 (56) 3.55 1.80 7.00 **p = 0.000
Sparse 9 6
Moderate 15 20
Profuse 47 26 p = 0.1053
(n = 100 women with mastitis and 99 breastfeeding controls). Melbourne, Australia, 2002–2004.
*chi-square test for all analyses.
**statistically significant.BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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and access to skilled help in the early postpartum days
and weeks.
This study found that using lanolin on nipples was signif-
icantly associated with mastitis on univariate analysis;
however this was no longer significant on multivariate
analysis. We expect that the association between creams
on nipples and mastitis [26] is more likely to be related to
the fact that nipple creams tend to be used when the nip-
ples are damaged, and it is the nipple damage that proba-
bly is the route by which infection enters the breast rather
than the creams themselves.
S. aureus was isolated in the milk of 46% of women with
mastitis, a similar proportion to studies over the last thirty
years [11]. S. aureus was also isolated in the milk of 17%
of women without mastitis; mostly reported as "sparse"
(11/15), probably reflecting contamination of the milk by
bacteria on the skin of the nipple or the hands. In other
studies between 0 and 20% of milk specimens from
healthy women are positive for S. aureus [27,28].
Although it is not possible to conclude whether transmis-
sion occurred from the infant to the mother's breast or
visa versa, it is likely that S. aureus was transmitted from
the infant to the mother. In 1957, Wysham and colleagues
demonstrated that 7 of 9 infants with positive throat cul-
tures for S. aureus transmitted the organism to their bottle
of formula milk [29]. Babies are born sterile and acquire
their colonisation from their mother or the hands of
health workers. Mothers and infants have been shown to
be likely to carry the same strain of S. aureus [25,30]. Sta-
phylococci may be transferred from the mother's nose to
the infant's and then back to the mother's nipple, particu-
larly if the nipple has been traumatised.
Strengths and limitations of this study
The diagnosis of mastitis relied on clinical signs and
symptoms as there are no definitive tests for mastitis in
women. The women in this study experienced either fever
or systemic symptoms for at least 12 hours. Future studies
could assess the usefulness of testing milk for the presence
of leukocytes [31]. Molecular microbiology (eg pulsed
field gel electrophoresis, PFGE) testing of isolates could
have confirmed the clonality of S. aureus strains present in
mothers with mastitis and in their infants. However, fund-
ing for this study was not sufficient to conduct PFGE.
It was originally planned to recruit women for the control
group through MCH centres in the community (n = 25).
However, we relied on women being referred to the study
and recruitment was slow, so we started recruiting women
Table 6: Logistic regression of a case control study of mastitis.
Univariate analysis Multivariate analysis Model 1 
(n = 192)
Multivariate analysis Model 2 (n = 192) 
(No demographic variables)
Odds Ratio (95% CI) Odds 
Ratio




<Aus$70,000 Reference Reference - - - -
>Aus$70,001 0.37 0.20 0.68 0.31 0.13 0.71 0.006 - - - -
Missing 0.67 0.22 2.06 0.28 0.06 1.14 0.120 - - - -
PHI
No Reference Reference - - - -
Yes 0.27 0.14 0.51 0.23 0.10 0.55 0.001 - - - -
Difficulty breastfeeding
No Reference Reference Reference
Yes 7.76 3.86 15.58 6.32 2.53 15.76 0.000 4.64 2.11 10.22 0.001
Cracked nipple
No Reference Reference Reference
Yes 15.02 5.60 40.33 9.34 2.99 29.20 0.000 9.39 3.24 27.21 0.000
Tight bra
No v Reference Reference
Yes 2.31 1.21 4.41 3.47 1.30 9.22 0.013 2.38 1.06 5.36 0.036
Baby nasal S. aureus
No Reference Reference Reference
Yes 3.70 1.85 7.40 3.23 1.30 8.27 0.017 2.70 1.19 6.14 0.018
Missing 4.56 1.41 14.71 3.49 0.78 15.50 0.101 3.20 0.83 12.38 0.092
(n = 98 women with mastitis and 94 breastfeeding controls). Melbourne, Australia, 2002–2004. Model 1 includes income, private health insurance, 
difficulty with breastfeeding, damaged nipple, tight bra, baby nasal S. aureus, and Model 2 includes difficulty with breastfeeding, damaged nipple, tight 
bra and baby nasal S. aureus.BMC Family Practice 2006, 7:57 http://www.biomedcentral.com/1471-2296/7/57
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attending a private obstetrician for their six-week postna-
tal check up. It would have been inappropriate to recruit
women attending the hospital (Emergency Department or
Breastfeeding clinic) as we were seeking women without
problems for the control group. Therefore the controls
were more likely to be private patients than cases, which
resulted in more women from the higher income group as
controls than cases. In order to assess if this had an effect
on the study results, a logistic regression model was devel-
oped using only women with private insurance and simi-
lar results were obtained as when the model included all
women.
A limitation of the case-control design is that any associa-
tions identified cannot be concluded to be causal. For
example, private health insurance appears to be protective
against mastitis (OR 0.27, 95%CI 0.14, 0.51), but this
association is due to the selection bias that occurred dur-
ing recruitment. The association between nasal S. aureus
carriage in infants and mastitis in their mothers (adjusted
OR 3.19, 1.23, 8.29) appears to be robust as it was signif-
icant in each logistic regression model. However, it does
not tell us if this association proves a link between nasal
carriage and mastitis nor in which direction the transmis-
sion is occurring.
Implications for clinical practice and future research
Mastitis is an acute painful illness, not limited to the
breast, and often associated with a negative emotional
response [20]. In order to prevent mastitis, clinicians
could advice new mothers about the factors commonly
associated with this problem, such as milk stasis caused by
missed feeds, expressing and breast restriction [32].
Breastfeeding women can be alert for the early symptoms
of mastitis when they have been extra busy, for example
when travelling or when they have visitors staying. If
women have anticipatory guidance they can overcome
milk stasis in these situations by increasing breastfeeds or
expressing more frequently.
Future studies need to aim to collect clinical specimens
prospectively in order to determine the transmission
dynamics between mother and infant. Molecular microbi-
ology (e.g. PFGE) can be used to confirm that the same
strain of S. aureus is present in mother and child, and the
direction of transmission of organisms between mother
and child.
It is not standard practice for mothers to wash hands
before breastfeeding (less than 50% of women in both
groups "always" washed hands). Future studies could
focus on hand washing as S. aureus may be carried tran-
siently on the hands [33] and can then be transferred to
the breast. Hospitals should be aware of the possibility of
transmission of potential pathogens on breast pumps; dis-
infection is particularly important after equipment is used
by women with breast infections.
Another topic for future research is recurrent mastitis.
Would it be possible to reduce recurrences of mastitis by
reducing nasal carriage of S. aureus in mothers and infants
where mothers have already experienced an episode of
mastitis?
Conclusion
In conclusion, we found no association between maternal
nasal carriage of S. aureus and mastitis, but nasal carriage
in the infant was associated with breast infections. As in
other studies of mastitis, we found a strong association
between nipple damage and mastitis.
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